Oric Pharmaceuticals, Inc. ORIC
13.16
(0.02)
(0.15%)
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 0.0×
Follow ORIC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| Current Ratio | 13.19 | 16.33 | 14.13 | 14.65 |
+8 more quarters Free account |
| Net Debt/EBITDA | 5.92 | 7.19 | 8.17 | 7.77 | |
| Debt/Assets | 0.00% | 0.00% | 0.00% | 0.00% | |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | 0.76 | 0.91 | 0.74 | 0.77 | |
| Capex/Depreciation | (0.64) | 0.00 | (2.84) | 0.12 | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Selling, General and Administrative Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Intangible Assets out of Total Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Free Cash Flow per Share | (0.30) | (0.31) | (0.26) | (0.25) | |
| Cash per Share | 2.45 | 2.67 | 3.21 | 2.90 | |
| Shareholders Equity per Share | 3.53 | 3.94 | 4.38 | 4.11 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 3.53 | 3.94 | 4.38 | 4.11 | |
| Free Cash Flow | (31.96) | (32.44) | (22.71) | (25.15) | |
| Working Capital | 252.94 | 272.46 | 268.05 | 275.42 | |
| Capital Expenditures | (0.36) | 0.00 | (0.23) | (0.03) | |
| Net Current Asset Value | 250.27 | 269.03 | 263.94 | 271.32 | |
| Other line items | |||||
| Quick Ratio | 12.76 | 15.86 | 13.79 | 14.23 | |
| Revenue per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF per Share | (0.29) | (0.31) | (0.26) | (0.25) | |
| Capex per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Average Payables | 3.50 | 4.03 | 2.69 | 3.57 | |
| Average Assets | 375.77 | 339.81 | 341.52 | 366.63 | |
| Average Common Equity | 352.63 | 317.65 | 313.74 | 340.46 | |
| Capex to Sales | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates